Propofol hemisuccinate suppresses cortical spreading depression

Neuroscience Letters

Volumn 514, Issue 1, 2012, Pages 67-70

  Dhir, Ashish ^a   Lossin, Christoph ^a   Rogawski, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cortical spreading depression; Dizocilpine; Migraine; Propofol hemisuccinate

Indexed keywords

ANTIMIGRAINE AGENT; DIZOCILPINE; PRODRUG; PROPOFOL; PROPOFOL HEMISUCCINATE; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEDATION; SINGLE DRUG DOSE; SPREADING CORTICAL DEPRESSION; VELOCITY;

ANESTHETICS; ANIMALS; CEREBRAL CORTEX; CORTICAL SPREADING DEPRESSION; MALE; MICE; MIGRAINE DISORDERS; MOTOR ACTIVITY; PRODRUGS; PROPOFOL; REFLEX, RIGHTING;

EID: 84859001837     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.02.058     Document Type: Article

References (31)

1. Akerman S., Goadsby P.J. Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. Neuroreport 2005, 16:1383-1387.
2. Anker-Møller E., Spangsberg N., Arendt-Nielsen L., Schultz P., Kristensen M.S., Bjerring P. Subhypnotic doses of thiopentone and propofol cause analgesia to experimentally induced acute pain. Br. J. Anaesth. 1991, 66:185-188.
3. Ayata C. Spreading depression: from serendipity to targeted therapy in migraine prophylaxis. Cephalalgia 2009, 29:1095-1114.
4. Ayata C., Jin J., Kudo C., Dalkara T., Moskowitz M.A. Suppression of cortical spreading depression in migraine prophylaxis. Ann. Neurol. 2006, 59:652-661.
5. Ayata C., Shimizu-Sasamata M., Lo E.H., Noebels J.L., Moskowitz M.A. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the α1A subunit of P/Q type calcium channels. Neuroscience 2000, 95:639-645.
6. Bansinath M., Shukla V.K., Turndorf H. Propofol modulates the effects of chemoconvulsants acting at GABAergic, glycinergic, and glutamate receptor subtypes. Anesthesiology 1995, 83:809-815.
7. Bloomstone J.A. Propofol: a novel treatment for breaking migraine headache. Anesthesiology 2007, 106:405-406.
8. Bogdanov V.B., Multon S., Chauvel V., Bogdanova O.V., Prodanov D., Makarchuk M.Y., Schoenen J. Migraine preventive drugs differentially affect cortical spreading depression in rat. Neurobiol. Dis. 2011, 41:430-435.
9. Bolay H., Moskowitz M.A. The emerging importance of cortical spreading depression in migraine headache. Rev. Neurol. (Paris) 2005, 161:655-657.
10. Borgeat A., Wilder-Smith O.H., Suter P.M. The nonhypnotic therapeutic applications of propofol. Anesthesiology 1994, 80:642-656.
11. Briggs L.P., Dundee J.W., Bahar M., Clarke R.S. Comparison of the effect of diisopropyl phenol (ICI 35, 868) and thiopentone on response to somatic pain. Br. J. Anaesth. 1982, 54:307-311.
12. Dhir A., Zolkowska D., Murphy R.B., Rogawski M.A. Seizure protection by intrapulmonary delivery of propofol hemisuccinate. J. Pharmacol. Exp. Ther. 2011, 336:215-222.
13. Drummond-Lewis J., Scher C. Propofol: a new treatment strategy for refractory migraine headache. Pain Med. 2002, 3:366-369.
14. Fassoulaki A. Is propofol an analgesic?. Eur. J. Anaesthesiol. 2011, 28:481-482.
15. Folkerts H. Migraine after electroconvulsive therapy. Convuls. Ther. 1995, 11:212-215.
16. Goadsby P.J. Can we develop neurally acting drugs for the treatment of migraine?. Nat. Rev. Drug Discov. 2005, 4:741-750.
17. Hoffmann U., Dileköz E., Kudo C., Ayata C. Gabapentin suppresses cortical spreading depression susceptibility. J. Cereb. Blood Flow Metab. 2010, 30:1588-1592.
18. Kaube H., Goadsby P.J. Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur. Neurol. 1994, 34:30-35.
19. Kitahara Y., Taga K., Abe H., Shimoji K. The effects of anesthetics on cortical spreading depression elicitation and c-fos expression in rats. J. Neurosurg. Anesthesiol. 2001, 13:26-32.
20. Krusz J.C., Scott V., Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache 2000, 40:224-230.
21. Lauritzen M., Hansen A.J. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J. Cereb. Blood Flow Metab. 1992, 12:223-229.
22. A receptors. Br. J. Anaesth. 2003, 90:199-211.
23. Marrannes R., Willems R., De Prins E., Wauquier A. Evidence for a role of the N-methyl-d-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res. 1988, 457:226-240.
24. Mendes P.M., Silberstein S.D., Young W.B., Rozen T.D., Paolone M.F. Intravenous propofol in the treatment of refractory headache. Headache 2002, 42:638-641.
25. Orser B.A., Bertlik M., Wang L.Y., MacDonald J.F. Inhibition by propofol (2,6-di-isopropylphenol) of the N-methyl-d-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br. J. Pharmacol. 1995, 116:1761-1768.
26. Ratnakumari L., Hemmings H.C. Effects of propofol on sodium channel-dependent sodium influx and glutamate release in rat cerebrocortical synaptosomes. Anesthesiology 1997, 86:428-439.
27. Richter F., Ebersberger A., Schaible H.G. Blockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depression. Neurosci. Lett. 2002, 334:123-126.
28. Roffey P., Thangathurai D. Propofol in the treatment of presurgical headache and nausea. Headache 2002, 42:327.
29. Vanlersberghe C., Camu F. Propofol. Handb. Exp. Pharmacol. 2008, 182:227-252.
30. Willette R.N., Lysko P.G., Sauermelch C.F. A comparison of (+)SK&F 10047 and MK-801 on cortical spreading depression. Brain Res. 1994, 648:347-351.
31. Zhang X., Levy D., Kainz V., Noseda R., Jakubowski M., Burstein R. Activation of central trigeminovascular neurons by cortical spreading depression. Ann. Neurol. 2011, 69:855-865.